172995-78-7

Upstream product

• 69739-34-0 t-butyldimethylsiyl triflate 
• 144900-82-3 (2R,5S)-5-benzyloxy-2-<(4S)-2,2-dimethyl-1,3-dioxolan-4-yl>heptan-4-one 
• 144534-88-3 (2R,4R,5S)-5-Benzyloxy-2-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-4-ethyl-heptan-4-ol 
• 144534-87-2 (E)-(S)-4-Benzyloxy-1-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-hex-1-en-3-one 
• 144534-85-0 dimethyl (3S)-3-benzyloxy-2-oxopentylphosphonate 

Downstream Products

• 144534-89-4 ((1R,2S)-2-Benzyloxy-1-ethyl-1-{(R)-2-[(S)-2-(4-methoxy-phenyl)-[1,3]dioxolan-4-yl]-propyl}-butoxy)-tert-butyl-dimethyl-silane 
• 144534-80-5 (2S,3R,5R,6S)-6-Benzyloxy-5-(tert-butyl-dimethyl-silanyloxy)-5-ethyl-2-(4-methoxy-benzyloxy)-3-methyl-octanal 
• 144534-90-7 (2S,3R,5R,6S)-6-Benzyloxy-5-(tert-butyl-dimethyl-silanyloxy)-5-ethyl-2-(4-methoxy-benzyloxy)-3-methyl-octan-1-ol 

Relevant academic research and scientific papers

Total Synthesis of the Polyether Antibiotic Lysocellin. 1. Stereocontrolled Synthesis of the C1-C9 and C16-C23 Fragments

Stereocontrolled synthesis of two fragments corresponding to the C1-C9 (3) and C16-C23 parts (6) of lysocellin (1) using hydroboration, Wittig-Horner reaction, and Michael reaction in the key steps is described. Key Words: Polyether antibiotic; Stereocont